CPRX
NASDAQ
$31.49
Catalyst Pharmaceuticals Inc (CPRX)
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, neuromuscular, and chronic neurological diseases in the United States. The company is headquartered in Coral Gables, Florida.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $31.67 (+0.57%)
Market Cap
$3.85B
EPS 5Y CAGR
+20.98%
Revenue 5Y CAGR
+37.80%
FCF 5Y CAGR
+38.59%
Price Chart
Valuation
Market Cap$3.85B
P/E17.44
Forward P/E12.95
PEG1.73
P/S6.46
P/B3.81
Profitability
Total Revenue (TTM)$597M
Gross Profit (TTM)$502M
EBITDA$268M
Profit Margin42.7%
Operating Margin49%
EPS$1.81
Financial Health
Free Cash Flow Yield5.41%
Growth & Risk
EPS 5Y CAGR+20.98%
Revenue 5Y CAGR+37.80%
FCF 5Y CAGR+38.59%
Beta (5Y)0.87
Sharpe Ratio1.33